We're taking on cancer.

Join the movement.

Watch video

reflexion x1. the time is now.

Be among the first to join the journey to BgRT.

Learn More

reflexion machine

Turning cancer on
itself > Finally

RefleXion’s biology-guided radiotherapy (BgRT) allows us to detect and respond to signals emitted from the cancer itself, and for the first time, use them to guide immediate treatment.

Real-Time Guidance

Cancer is talking.
We’re listening.

When PET radiotracers are introduced into the body, cancer absorbs them and acts as a biological beacon, which our machine can use to track and treat cancer in real time.

Learn More About Emissions

Targeting Cancer

Good news for organs. Bad news for tumors.

Our technology aims to deliver high doses of radiation to tumors, even while in motion, for greater impact to the tumor with less dose to the surrounding tissue.

Learn About Targeting

Metastatic Disease

A world where stage is just a number.

Most patients with stage four cancer are not considered candidates for definitive radiotherapy due to the challenge of treating multiple tumors. Our breakthrough technology is challenging that and aims to treat multiple tumors, in parallel, during a single session. 

Discover the Potential

Combination Treatment

Come at cancer from every angle.

Treatment isn’t a one-size-fits-all situation. For many patients, the best treatment plan is a combination of multiple therapies. RefleXion will work together with chemotherapy, immunotherapy and targeted drugs for potentially better outcomes.

Learn About Treatment

Learn more about RefleXion

RefleXion BGRT

By combining PET-CT and radiotherapy, we're able to find and treat cancer using its own emissions.

Clinicians

Discover RefleXion Therapy.

Cancer Centers

See how RefleXion Therapy can play a role
in your cancer program.

Make every day count

See Available Positions

Latest

Press Releases

RefleXion and Telix Pharmaceuticals Announce Strategic Collaboration for Treatment of High-Risk Cancers

HAYWARD, Calif., and MELBOURNE, Australia, July 8, 2020 – RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a new modality for treating all stages of cancer, and Telix Pharmaceuticals Limited (ASX: TLX), a radiopharmaceutical company developing molecularly-targeted radiation (MTR) products, today announced a strategic collaboration to investigate the clinical utility of combining […]

View All Press chevron right

Blog

A ‘Big, Crazy Idea’ He Couldn’t Ignore

Antoine Papiernik is managing partner and chairman of Sofinnova Partners. He has served on RefleXion Medical’s board of directors since 2014. He was the company’s first institutional investor. If anyone can spot a winning investment, it’s Antoine Papiernik. He’s been picking winners for more than 20 years. “My three key criteria are: people, people, and […]

View All Blog Posts chevron right

Feedback
and
Inquiries.

Let us tell you more.

Contact Us

Sign up for our
latest news and information.

Stay up to date.

Sign Up